Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 38
Filter
1.
Pharmaceutics ; 16(1)2024 Jan 17.
Article in English | MEDLINE | ID: mdl-38258128

ABSTRACT

Pseudomonas aeruginosa is one of the most common microorganisms causing infections of severe skin wounds. Antibiotic or antiseptic treatments are crucial to prevent and curb these infections. Antiseptics have been reported to be cytotoxic to skin cells and few studies evaluate the impact of commonly used antibiotics. This study evaluates how clinical antibiotics affect skin cells' viability, proliferation, migration, and cytokine secretion and defines the highest non-cytotoxic concentrations that maintain antibacterial activity. Cell proliferation, viability, and migration were evaluated on cell monolayers. Cytokines related to the wound healing process were determined. The minimum inhibitory concentrations and the impact on bacterial biofilm were assessed. Results showed that 0.02 mg/mL ciprofloxacin and 1 mg/mL meropenem are the highest non-cytotoxic concentrations for fibroblasts and keratinocytes while 1.25 mg/mL amikacin and 0.034 mg/mL colistin do not affect fibroblasts' viability and cytokine secretion but have an impact on keratinocytes. These concentrations are above the minimum inhibitory concentration but only amikacin could eradicate the biofilm. For the other antibiotics, cytotoxic concentrations are needed to eradicate the biofilm. Combinations with colistin at non-cytotoxic concentrations effectively eliminate the biofilm. These results provide information about the concentrations required when administering topical antibiotic treatments on skin lesions, and how these antibiotics affect wound management therapies. This study set the basis for the development of novel antibacterial wound healing strategies such as antibiotic artificial skin substitutes.

2.
Int J Mol Sci ; 24(24)2023 Dec 14.
Article in English | MEDLINE | ID: mdl-38139289

ABSTRACT

Androgenic alopecia (AGA) is the most prevalent type of progressive hair loss and has psychological repercussions. Nevertheless, the effectiveness of current pharmacological treatments remains limited, in part because the molecular basis of the disease has not been fully elucidated. Our group previously highlighted the important roles of aromatase and 5α-reductase (5α-R) in alopecia in young women with female pattern hair loss. Additionally, an association has been proposed between AGA and prostate cancer (PCa), suggesting that genes implicated in PCa would also be involved in AGA. A low-invasive, sensitive, and precise method was used to determine mRNA levels of aromatase, 5α-R isozymes, and 84 PCa-related genes in samples of plucked hair from young men with AGA and controls. Samples were obtained with a trichogram from the vertex scalp, and mRNA levels were quantified using real-time RT-PCR. The men with AGA had significantly higher 5α-R2 mRNA levels in comparison to controls; interestingly, some of them also showed markedly elevated mRNA levels of 5α-R1 or 5α-R3 or of both, which may explain the varied response to 5α-R inhibitor treatments. The men with AGA also showed significant changes versus controls in 6 out of the 84 genes implicated in PCa. This study contributes greater knowledge of the molecular bases of AGA, facilitating early selection of the most appropriate pharmacological therapy and opening the way to novel treatments.


Subject(s)
Cholestenone 5 alpha-Reductase , Prostatic Neoplasms , Male , Humans , Cholestenone 5 alpha-Reductase/genetics , Aromatase/genetics , Isoenzymes/therapeutic use , RNA, Messenger/genetics , Hair , Alopecia/genetics , Alopecia/drug therapy , Prostatic Neoplasms/genetics
4.
Biology (Basel) ; 11(8)2022 Aug 06.
Article in English | MEDLINE | ID: mdl-36009810

ABSTRACT

Proteomics methods can identify amino acid sequences in fossil proteins, thus making it possible to determine the ascription or proximity of a fossil to other species. Before mass spectrometry was used to study fossil proteins, earlier studies used antibodies to recognize their sequences. Lowenstein and colleagues, at the University of San Francisco, pioneered the identification of fossil proteins with immunological methods. His group, together with Olivares's group at the University of Granada, studied the immunological reactions of proteins from the controversial Orce skull fragment (VM-0), a 1.3-million-year-old fossil found at the Venta Micena site in Orce (Granada province, southern Spain) and initially assigned to a hominin. However, discrepancies regarding the morphological features of the internal face of the fossil raised doubts about this ascription. In this article, we review the immunological analysis of the proteins extracted from VM-0 and other Venta Micena fossils assigned to hominins and to other mammals, and explain how these methods helped to determine the species specificity of these fossils and resolve paleontological controversies.

5.
Environ Res ; 212(Pt A): 113142, 2022 09.
Article in English | MEDLINE | ID: mdl-35378123

ABSTRACT

The synergetic effect of estrogens and androgens is known to play a crucial role in the physiopathology of the prostate gland. Bisphenol A (BPA) is an endocrine disrupting compound that can interfere with endocrine hormone functioning and thereby influence prostate development. The objective of this study was to examine the impact on prostate expression of aromatase, 5α-R isozymes, and prostate cancer-related genes of exposure to low doses of BPA from perinatal period to adulthood. Vehicle or BPA (2.5 µg/kg b.w./day) was administered to gestating Wistar rats from gestational day 12 (GD12) to parturition and then to their male pups from postnatal day 1 (PND1) until euthanization on PND90. Their prostate glands were examined by qRT-PCR, Western blot, PCR array, and morphological study. mRNA and protein levels of 5α-R2 were significantly reduced and mRNA and protein levels of aromatase were significantly increased in BPA-treated animals, which also showed modifications of 8 out of the 84 key genes implicated in the development of prostate cancer. Because BPA interferes with genes involved in intraprostatic androgen and estrogen production and others implicated in prostate cancer, research is warranted into the prostate disease risk associated with chronic low-dose BPA exposure throughout life.


Subject(s)
Cholestenone 5 alpha-Reductase , Prostatic Neoplasms , Adult , Androgens , Animals , Aromatase/genetics , Aromatase/metabolism , Benzhydryl Compounds/toxicity , Cholestenone 5 alpha-Reductase/genetics , Cholestenone 5 alpha-Reductase/metabolism , Humans , Isoenzymes/genetics , Isoenzymes/metabolism , Male , Parturition , Phenols , Pregnancy , Prostatic Neoplasms/chemically induced , Prostatic Neoplasms/genetics , RNA, Messenger/metabolism , Rats , Rats, Wistar , Testosterone/metabolism
6.
Article in English | MEDLINE | ID: mdl-32850740

ABSTRACT

The 22 genetically encoded amino acids (AAs) present in proteins (the 20 standard AAs together with selenocysteine and pyrrolysine), are commonly referred as proteinogenic AAs in the literature due to their appearance in ribosome-synthetized polypeptides. Beyond the borders of this key set of compounds, the rest of AAs are generally named imprecisely as non-proteinogenic AAs, even when they can also appear in polypeptide chains as a result of post-transductional machinery. Besides their importance as metabolites in life, many of D-α- and L-α-"non-canonical" amino acids (NcAAs) are of interest in the biotechnological and biomedical fields. They have found numerous applications in the discovery of new medicines and antibiotics, drug synthesis, cosmetic, and nutritional compounds, or in the improvement of protein and peptide pharmaceuticals. In addition to the numerous studies dealing with the asymmetric synthesis of NcAAs, many different enzymatic pathways have been reported in the literature allowing for the biosynthesis of NcAAs. Due to the huge heterogeneity of this group of molecules, this review is devoted to provide an overview on different established multienzymatic cascades for the production of non-canonical D-α- and L-α-AAs, supplying neophyte and experienced professionals in this field with different illustrative examples in the literature. Whereas the discovery of new or newly designed enzymes is of great interest, dusting off previous enzymatic methodologies by a "back and to the future" strategy might accelerate the implementation of new or improved multienzymatic cascades.

7.
Front Pharmacol ; 11: 613068, 2020.
Article in English | MEDLINE | ID: mdl-33551815

ABSTRACT

Both TRPA1 and purinergic P2X receptors have been proposed as potential targets for the treatment of visceral pain. We found that the intracolonic administration of a low dose mustard oil (0.5%), a well-known TRPA1 agonist, produced nociceptive responses and abdominal wall referred mechanical hyperalgesia, without inducing apparent tissue damage. Both nociceptive responses and referred hyperalgesia were abolished by the ablation of TRPV1-expressing neurons (and the consequent ablation of TRPA1+ nociceptors) by resiniferatoxin (RTX) treatment, and by the TRPA1 antagonist AP18. However, a higher dose of mustard oil (2.5%) damaged the colonic epithelium and induced pERK activation in the spinal cord, and these processes were clearly independent of TRPV1-expressing neurons ablated by RTX. This higher dose of mustard oil induced nociceptive responses and referred mechanical hyperalgesia which were insensitive or only slightly sensitive to resiniferatoxin or AP18, but were markedly reduced by the P2X antagonist TNP-ATP, which is known to inhibit nociceptive actions induced by ATP released from injured tissues. In conclusion, whereas a low dose of intracolonic mustard oil induces visceral pain in a manner fully dependent on TRPA1 actions, when a high dose of this chemical irritant is used, visceral pain becomes mostly independent of TRPA1 activation but clearly enhanced by ATP purportedly released by the damaged colonic epithelium. Therefore, TRPA1 inhibition is not sufficient to substantially decrease visceral pain during tissue injury, whereas purinergic antagonism appears to be a more effective strategy.

8.
Food Chem Toxicol ; 115: 20-25, 2018 May.
Article in English | MEDLINE | ID: mdl-29501275

ABSTRACT

The impact of bisphenol A (BPA) on the prostate gland has taken center stage, with a special focus placed on understanding how BPA affects prostate physiopathology. In this study, we evaluated the ability of lower doses of BPA to induce alterations in 5α-R isozymes and aromatase, in the prostate of juvenile rats exposed during developmental stage. Gestating Wistar rats were treated s.c with either vehicle or BPA (2.4 and 10 µg/kg b.w./day) from gestational day 12 to parturition. Then, male pups were s.c treated from postnatal day 1 through day 21, when they were euthanized and qRT-PCR, western blot and hormone levels determination were performed. We found that BPA at dose of 2.4 and 10 µg/kg b.w./day significantly decreased the mRNA and protein levels of 5α-R2. However, neither 5α-R1 nor 5α-R3 was affected by this exposure. BPA at dose of 10 µg/kg b.w./day significantly increased the mRNA and protein levels of aromatase. BPA also decreased plasma levels of both testosterone and dihydrotestosterone and increased estradiol. These data lend support that low-dose BPA during fetal and neonatal prostate development interfere with in situ estrogen and androgen production in the prostate gland of juvenile rats through the enzymes aromatase and 5α-Reductase.


Subject(s)
Aromatase/metabolism , Benzhydryl Compounds/toxicity , Cholestenone 5 alpha-Reductase/metabolism , Phenols/toxicity , Prostate/drug effects , Prostate/enzymology , Androgens/metabolism , Animals , Aromatase/genetics , Cholestenone 5 alpha-Reductase/genetics , Female , Isoenzymes/genetics , Isoenzymes/metabolism , Male , Maternal Exposure/adverse effects , Prostate/growth & development , Rats , Rats, Wistar , Testosterone/metabolism
9.
Brain ; 141(2): 365-376, 2018 02 01.
Article in English | MEDLINE | ID: mdl-29253101

ABSTRACT

Chronic pain is a major global public health issue causing a severe impact on both the quality of life for sufferers and the wider economy. Despite the significant clinical burden, little progress has been made in terms of therapeutic development. A unique approach to identifying new human-validated analgesic drug targets is to study rare families with inherited pain insensitivity. Here we have analysed an otherwise normal family where six affected individuals display a pain insensitive phenotype that is characterized by hyposensitivity to noxious heat and painless bone fractures. This autosomal dominant disorder is found in three generations and is not associated with a peripheral neuropathy. A novel point mutation in ZFHX2, encoding a putative transcription factor expressed in small diameter sensory neurons, was identified by whole exome sequencing that segregates with the pain insensitivity. The mutation is predicted to change an evolutionarily highly conserved arginine residue 1913 to a lysine within a homeodomain. Bacterial artificial chromosome (BAC) transgenic mice bearing the orthologous murine p.R1907K mutation, as well as Zfhx2 null mutant mice, have significant deficits in pain sensitivity. Gene expression analyses in dorsal root ganglia from mutant and wild-type mice show altered expression of genes implicated in peripheral pain mechanisms. The ZFHX2 variant and downstream regulated genes associated with a human pain-insensitive phenotype are therefore potential novel targets for the development of new analgesic drugs.awx326media15680039660001.


Subject(s)
Pain Insensitivity, Congenital/genetics , Pain Threshold/physiology , Pain/physiopathology , Point Mutation/genetics , Zinc Finger E-box Binding Homeobox 2/genetics , Action Potentials/drug effects , Action Potentials/physiology , Adolescent , Adult , Aged , Animals , Calcium/metabolism , Capsaicin/adverse effects , Disease Models, Animal , Female , Ganglia, Spinal/pathology , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Humans , Hyperalgesia/pathology , Hyperalgesia/physiopathology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Middle Aged , Pain/chemically induced , Pain Insensitivity, Congenital/pathology , Pain Insensitivity, Congenital/physiopathology , Sensory Receptor Cells/drug effects , Sensory Receptor Cells/physiology , Skin/pathology , Young Adult
10.
Chemosphere ; 139: 235-9, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26141625

ABSTRACT

There is concern that exposure of embryos and/or infants to bisphenol A (BPA) may lead to neurological and behavioral disorders with unknown prefrontal cortex (PFC) involvement. Critical PFC functions are modulated by dopamine (DA) and serotonin (5-HT) systems, whose alterations have been associated with psychopathologies that may appear in youth and/or adulthood. This study aims to determine in the PFC of male rats exposed to a low dose of BPA (10µgkg(-1)d(-1)) from gestational day 12 (GD12) to postnatal day 21 (PND21): (i) DA- and 5-HT-related genes modulated by BPA at the juvenile stage (PND21); (ii) reversible and irreversible transcriptional effects; (iii) long-term consequences (effects in adult rats, PND90). In juvenile rats, BPA altered significantly the transcription of 12 out of the 84 genes analyzed using PCR-array techniques. Interestingly, transcript levels of the neurotrophic factor Gdnf were decrease by BPA in both juvenile and adult rats. At adulthood, disruptions in genes encoding rate-limiting enzymes for DA and 5-HT synthesis emerged. Overall, the results indicate that early-life exposure to BPA has consequences on DA and 5-HT systems in both juvenile- and adult-life stages. Additionally, we reveal molecular targets that could provide the foundation for future BPA neurotoxicity studies.


Subject(s)
Benzhydryl Compounds/toxicity , Dopamine/metabolism , Phenols/toxicity , Prefrontal Cortex/drug effects , Serotonin/metabolism , Animals , Animals, Newborn , Female , Gene Expression Regulation/drug effects , Glial Cell Line-Derived Neurotrophic Factor/genetics , Male , Maternal-Fetal Exchange , Prefrontal Cortex/metabolism , Pregnancy , Prenatal Exposure Delayed Effects , Rats, Wistar
11.
Environ Res ; 142: 281-7, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26186136

ABSTRACT

BACKGROUND: Early-life exposure to the endocrine disruptor bisphenol A (BPA) affects brain function and behavior, which might be attributed to its interference with hormonal steroid signaling and/or neurotransmitter systems. Alternatively, the use of structural analogs of BPA, mainly bisphenol F (BPF) and bisphenol S (BPS), has increased recently. However, limited in vivo toxicity data exist. OBJECTIVES: We investigated the effects of BPA, BPF and BPS on 5α-reductase (5α-R), a key enzyme involved in neurosteroidogenesis, as well as on dopamine (DA)- and serotonin (5-HT)-related genes, in the prefrontal cortex (PFC) of juvenile female rats. METHODS: Gestating Wistar rats were treated with either vehicle or 10 µg/kg/day of BPA, BPF or BPS from gestational day 12 to parturition. Then, female pups were exposed from postnatal day 1 through day 21 (PND21), when they were euthanized and RT-PCR, western blot and quantitative PCR-array experiments were performed. RESULTS: BPA decreased 5α-R2 and 5α-R3 mRNA and protein levels, while both BPF and BPS decreased 5α-R3 mRNA levels in PFC at PND21. Further, BPA, BPF and BPS significantly altered, respectively, the transcription of 25, 56 and 24 genes out of the 84 DA and 5-HT-related genes assayed. Of particular interest was the strong induction by all these bisphenols of Cyp2d4, implicated in corticosteroids synthesis. CONCLUSIONS: Our results demonstrate for the first time that BPA, BPF and BPS differentially affect 5α-R and genes related to DA/5-HT systems in the female PFC. In vivo evidence of the potential adverse effects of BPF and BPS in the brain of mammals is provided in this work, raising questions about the safety of these chemicals as substitutes for BPA.


Subject(s)
Benzhydryl Compounds/pharmacology , Cholestenone 5 alpha-Reductase/metabolism , Phenols/pharmacology , Prefrontal Cortex/drug effects , Sulfones/pharmacology , Animals , Cholestenone 5 alpha-Reductase/genetics , Dopamine , Female , Gene Expression/drug effects , Isoenzymes/genetics , Isoenzymes/metabolism , Prefrontal Cortex/metabolism , RNA, Messenger/metabolism , Rats, Wistar , Serotonin
12.
Psychopharmacology (Berl) ; 231(17): 3273-80, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24714925

ABSTRACT

RATIONALE: Underage drinking is a leading public health problem in developed countries. An increasing proportion of adolescents consume alcoholic beverages every weekend. Increased anxiety, irritability, and depression among adolescents may induce them to seek for the anxiolytic and rewarding properties of alcohol. Allopregnanolone (AlloP) shares rewarding effects of ethanol and modulates ethanol intake. The rate-limiting enzyme in the biosynthesis of AlloP is steroid 5α-reductase (5α-R), which is expressed as three isozymes, 5α-R1, 5α-R2, and 5α-R3. OBJECTIVE: The objective of this study was to quantify the expression levels of 5α-R isozymes in prefrontal cortex (PFC) of adolescent male rats after three different regimes of ethanol administration. METHODS: Adolescent male Wistar rats were administered with ethanol (4 g/kg) or saline intraperitoneally for 1 day (acute), for 7 days (chronic), or every 72 h for 14 days (chronic intermittent). Messenger (m)RNA and protein levels of 5α-R isozymes were measured by quantitative RT-PCR and Western blot, respectively. RESULTS: Ethanol significantly increased mRNA and protein levels of 5α-R1, 5α-R2, and 5α-R3 in the three different regimes of ethanol administration, being higher in the chronic intermittent regime in comparison with the others. CONCLUSIONS: The expression of the AlloP-biosynthetic enzyme 5α-Rs increases in the prefrontal cortex of adolescent male rats under acute, chronic, and chronic intermittent regime of ethanol administration. The latter is very interesting because it mimics the teenage drinking behavior.


Subject(s)
3-Oxo-5-alpha-Steroid 4-Dehydrogenase/biosynthesis , Central Nervous System Depressants/pharmacology , Ethanol/pharmacology , Prefrontal Cortex/metabolism , RNA, Messenger/biosynthesis , Alcoholism/enzymology , Alcoholism/metabolism , Animals , Binge Drinking/enzymology , Binge Drinking/metabolism , Central Nervous System Depressants/administration & dosage , Ethanol/administration & dosage , Isoenzymes/biosynthesis , Male , Prefrontal Cortex/drug effects , Prefrontal Cortex/enzymology , Rats , Rats, Wistar
13.
PLoS One ; 8(9): e73584, 2013.
Article in English | MEDLINE | ID: mdl-24066056

ABSTRACT

Several neurological and behavioral dysfunctions have been reported in animals exposed to bisphenol A (BPA). However, little is known about the impact of adult exposure to BPA on brain physiopathology. Here, we focused on prefrontal cortex (PFC) of rats, because it is an important area for cognitive control, complex behaviors and is altered in many psychopathologies. Gamma-aminobutyric acid (GABA) and serotonin (5-HT) systems are essential for PFC function. Therefore, we examined the effects of adult exposure to BPA on 5α-Reductase (5α-R) and cytochrome P450 aromatase (P450arom), enzymes that synthesize GABAA receptor modulators, and tryptophan hydroxylase (Tph), the rate-limiting enzyme in 5-HT biosynthesis. To gain better understanding of BPA's action in the adult PFC, 84 genes involved in neurotoxicity were also analysed. Adult male and female rats were subcutaneously injected for 4 days with 50 µg/kg/day, the current reference safe dose for BPA. mRNA and protein levels of 5α-R, P450arom and Tph were quantified by real-time RT-PCR and Western blot. Genes linked to neurotoxicity were analyzed by PCR-Array technology. Adult exposure to BPA increased both P450arom and Tph2 expression in PFC of male and female, but decreased 5α-R1 expression in female. Moreover, we identified 17 genes related to PFC functions such as synaptic plasticity and memory, as potential targets of BPA. Our results provided new insights on the molecular mechanisms underlying BPA action in the physiopathology of PFC, but also raise the question about the safety of short-term exposure to it in the adulthood.


Subject(s)
Benzhydryl Compounds/toxicity , Phenols/toxicity , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Animals , Aromatase/genetics , Aromatase/metabolism , Blotting, Western , Cholestenone 5 alpha-Reductase/genetics , Cholestenone 5 alpha-Reductase/metabolism , Female , Male , Rats , Real-Time Polymerase Chain Reaction , Tryptophan Hydroxylase/genetics , Tryptophan Hydroxylase/metabolism
14.
Biomed Res Int ; 2013: 629235, 2013.
Article in English | MEDLINE | ID: mdl-23984391

ABSTRACT

The development, growth, and function of the prostate gland depend on androgen stimulation. The primary androgen in prostate is 5α-dihydrotestosterone (DHT) which is synthesized from circulating testosterone (T) through the action of 5α-reductase (5α-R). Although 5α-R occurs as five isozymes, only 5α-R1 and 5α-R2 are physiologically involved in steroidogenesis. The endocrine disruptor bisphenol A (BPA) alters sexual organs, including the prostate. Our previous findings indicated that BPA decreased the expression of 5α-R1 and 5α-R2 in rat prostate but also circulating T. Thus, it is unclear whether BPA exerts this effect on 5α-R isozymes by reducing circulating T or by any other mechanism. In this study, we examine the effects of short-term exposure to BPA at doses below 25 µg/Kg/d and above 300 µg/Kg/d of the TDI on mRNA levels of 5α-R1 and 5α-R2 in prostate of adult castrated rats supplemented with T to achieve constant circulating T levels. mRNA levels were measured by absolute quantitative RT-PCR, T levels by RIA, and DHT levels by ELISA. Our results indicated that in castrated rats treated with T BPA at the two doses studied significantly decreased the mRNA levels of both 5α-R isozymes in a dose-dependent manner without modifications in circulating T.


Subject(s)
Benzhydryl Compounds/toxicity , Cholestenone 5 alpha-Reductase/metabolism , Phenols/toxicity , Prostate/drug effects , Prostate/enzymology , Testosterone/pharmacology , Animals , Castration , Cholestenone 5 alpha-Reductase/genetics , Dihydrotestosterone/blood , Gene Expression Regulation, Enzymologic/drug effects , Isoenzymes/genetics , Isoenzymes/metabolism , Male , Organ Size/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Wistar , Testosterone/blood
15.
J. physiol. biochem ; 69(1): 133-140, mar. 2013.
Article in English | IBECS | ID: ibc-121995

ABSTRACT

The rising incidence of prostate cancer and benign prostatic hypertrophy in the Western world is a cause of increasing public health concern. The most active androgen in the prostate is 5á-dihydrotestosterone obtained from testosterone (T) by the enzyme 5á-reductase (5á-R), expressed in the prostate as two isozymes, 5á-R1 and 5á-R2. These isozymes are involved in the growth and development of normal prostate and in the onset and progression of prostate disease. Besides androgens, prolactin (PRL) may also play a role, although it is not clear whether its effects on the prostate are in synergism with or independent of those of androgens. We previously demonstrated that sulpiride, an inductor of hyperprolactinemia, increased mRNA levels of 5á-R isozymes in prostate of adult rat. We hypothesized a possible interrelationship between PRL levels and 5á-R, although the effects of sulpiride per se cannot be ruled out. In the present study, one-step quantitative reverse transcription polymerase chain reaction coupled with laser-induced fluorescence capillary electrophoresis was used to quantify mRNA levels of both 5á-R isozymes in prostate of adult rat after administration of metoclopramide (MTC), another inductor of PRL secretion. With the administration regimens studied, MTC produced an increase in prostate weight and mRNA levels of 5á-R1 and 5á-R2 in adult rats. Given our finding that MTC per se or MTC-induced hyperprolactinemia modifies prostate disease-related parameters in animals with reduced plasma T levels, further investigation is warranted into the possibility that MTC use by aging males may increase their risk of prostate disease (AU)


Subject(s)
Animals , Male , Rats , Prostate , Metoclopramide/pharmacokinetics , RNA, Messenger , Isoenzymes , Dihydrotestosterone/pharmacokinetics , Risk Factors , Prostatic Neoplasms/chemically induced , Prostatic Hyperplasia/chemically induced
16.
PLoS One ; 8(2): e55905, 2013.
Article in English | MEDLINE | ID: mdl-23405234

ABSTRACT

The high incidence of prostate cancer (PCa) and benign prostatic hypertrophy (BPH) in elderly men is a cause of increasing public health concern. In recent years, various environmental endocrine disruptors, such as bisphenol A (BPA), have been shown to disrupt sexual organs, including the prostate gland. However, the mechanisms underlying these effects remain unclear. Because androgens and estrogens are important factors in prostate physiopathology, our objective was to examine in rat ventral prostate the effects of adult exposure to BPA on 5α-Reductase isozymes (5α-R types 1, 2, and 3) and aromatase, key enzymes in the biosynthesis of dihydrotestosterone and estradiol, respectively. Adult rats were subcutaneously injected for four days with BPA (25, 50, 300, or 600 µg/Kg/d) dissolved in vehicle. Quantitative RT-PCR, western blot and immunohistochemical analyses showed lower mRNA and protein levels of 5α-R1 and 5α-R2 in BPA-treated groups versus controls but higher mRNA levels of 5α-R3, recently proposed as a biomarker of malignancy. However, BPA treatment augmented mRNA and protein levels of aromatase, whose increase has been described in prostate diseases. BPA-treated rats also evidenced a higher plasma estradiol/testosterone ratio, which is associated with prostate disease. Our results may offer new insights into the role of BPA in the development of prostate disease and may be of great value for studying the prostate disease risk associated with exposure to BPA in adulthood.


Subject(s)
3-Oxo-5-alpha-Steroid 4-Dehydrogenase/metabolism , Aromatase/metabolism , Benzhydryl Compounds/pharmacology , Estrogens, Non-Steroidal/pharmacology , Membrane Proteins/metabolism , Phenols/pharmacology , Prostate/metabolism , Prostatic Hyperplasia/metabolism , 3-Oxo-5-alpha-Steroid 4-Dehydrogenase/genetics , Animals , Aromatase/genetics , Blotting, Western , Estradiol/blood , Immunoenzyme Techniques , Isoenzymes , Male , Membrane Proteins/genetics , Prostate/drug effects , Prostatic Hyperplasia/drug therapy , Prostatic Hyperplasia/genetics , RNA, Messenger/genetics , Rats , Rats, Wistar , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Testosterone/blood
17.
J Physiol Biochem ; 69(1): 133-40, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22806172

ABSTRACT

The rising incidence of prostate cancer and benign prostatic hypertrophy in the Western world is a cause of increasing public health concern. The most active androgen in the prostate is 5α-dihydrotestosterone obtained from testosterone (T) by the enzyme 5α-reductase (5α-R), expressed in the prostate as two isozymes, 5α-R1 and 5α-R2. These isozymes are involved in the growth and development of normal prostate and in the onset and progression of prostate disease. Besides androgens, prolactin (PRL) may also play a role, although it is not clear whether its effects on the prostate are in synergism with or independent of those of androgens. We previously demonstrated that sulpiride, an inductor of hyperprolactinemia, increased mRNA levels of 5α-R isozymes in prostate of adult rat. We hypothesized a possible interrelationship between PRL levels and 5α-R, although the effects of sulpiride per se cannot be ruled out. In the present study, one-step quantitative reverse transcription polymerase chain reaction coupled with laser-induced fluorescence capillary electrophoresis was used to quantify mRNA levels of both 5α-R isozymes in prostate of adult rat after administration of metoclopramide (MTC), another inductor of PRL secretion. With the administration regimens studied, MTC produced an increase in prostate weight and mRNA levels of 5α-R1 and 5α-R2 in adult rats. Given our finding that MTC per se or MTC-induced hyperprolactinemia modifies prostate disease-related parameters in animals with reduced plasma T levels, further investigation is warranted into the possibility that MTC use by aging males may increase their risk of prostate disease.


Subject(s)
3-Oxo-5-alpha-Steroid 4-Dehydrogenase/metabolism , Dopamine Antagonists/pharmacology , Metoclopramide/pharmacology , Prolactin/agonists , Prostate/drug effects , RNA, Messenger/biosynthesis , Animals , Dose-Response Relationship, Drug , Isoenzymes/metabolism , Male , Organ Size/drug effects , Prolactin/blood , Prostate/metabolism , RNA, Messenger/genetics , Rats , Rats, Wistar , Sulpiride/pharmacology , Testosterone/antagonists & inhibitors , Testosterone/blood
18.
FEBS J ; 280(1): 93-101, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23122426

ABSTRACT

The elevated incidence of prostate cancer and benign prostatic hypertrophy is a cause of increasing public health concern in the Western world. The normal and pathological growth of the prostate are both dependent on stimulation by dihydrotestosterone, which is synthesized from circulating testosterone by two 5α-reductase (5α-R) isozymes, 5α-reductase type 1 (5α-R1) and 5α-reductase type 2 (5α-R2). Both isozymes have been implicated in prostate disease. We used quantitative RT-PCR and immunohistochemistry, respectively, to quantify mRNA and protein levels of 5α-R isozymes in the ventral prostate of adult rats under environmental stress conditions analogous to those found in some common workplace situations, i.e. artificial light, excessive heat, and the sensation of immobility in a small space. Transcription and expression levels of both 5α-R isozymes were significantly higher in environmentally stressed rats than in unstressed rats. Increased 5α-R isozyme levels may play a role in the development or maintenance of prostate disease. Further research is warranted to explore these effects of environmental stress on human health and their implications for environmental and occupational health policies.


Subject(s)
3-Oxo-5-alpha-Steroid 4-Dehydrogenase/metabolism , Membrane Proteins/metabolism , Prostate/enzymology , Stress, Psychological/enzymology , 3-Oxo-5-alpha-Steroid 4-Dehydrogenase/genetics , Adrenocorticotropic Hormone/blood , Animals , Corticosterone/blood , Dihydrotestosterone/metabolism , Gene Expression , Gene Expression Regulation, Enzymologic , Hot Temperature , Isoenzymes/genetics , Isoenzymes/metabolism , Lighting , Male , Membrane Proteins/genetics , Prolactin/blood , Prostate/metabolism , Rats , Rats, Wistar , Restraint, Physical , Stress, Physiological , Stress, Psychological/blood
19.
Mol Cell Biochem ; 374(1-2): 21-7, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23124853

ABSTRACT

The increased vascular calcification, cardiovascular morbidity, and mortality in chronic kidney disease (CKD) patients has been associated with disturbances in mineral-bone metabolism. In order to determine markers of the vascular calcification frequently observed in these patients, blood samples of elderly male and female hemodialysis CKD patients were used to measure serum levels of: osteoprotegerin (OPG), total soluble receptor activator of nuclear factor-κB ligand (sRANKL), and fetuin-A by enzyme immunoassay; tartrate-resistant acid phosphatase (TRACP-5b), and bone-specific alkaline phosphatase (BAP) by immunoenzymometric assay; osteocalcin (OC) by ELISA; iPTH by immunoradiometric assay; 25(OH)D(3) and 1,25(OH)(2)D(3), by I(125) radioimmunoassay; and calcium and phosphorus by photometric assay. Serum OPG, BAP, iPTH, phosphorus, and OC levels were higher and serum 25(OH)D(3), 1,25(OH)(2)D(3), and fetuin-A levels lower in both male and female CKD patients than in their respective controls. Our results indicate that the bone formation and resorption parameters are altered in elderly male and female hemodialysis CKD patients. These changes may lead to vascular calcifications and cardiovascular complications, given that elevated OPG and OC levels and reduced fetuin-A levels are associated with cardiovascular events.


Subject(s)
Cardiovascular Diseases/blood , Renal Insufficiency, Chronic/blood , Vascular Calcification/blood , Acid Phosphatase/blood , Aged , Alkaline Phosphatase/blood , Biomarkers/blood , Female , Humans , Isoenzymes/blood , Male , Middle Aged , Osteoprotegerin/blood , RANK Ligand/blood , Renal Dialysis , Renal Insufficiency, Chronic/metabolism , Renal Insufficiency, Chronic/pathology , Tartrate-Resistant Acid Phosphatase , alpha-2-HS-Glycoprotein/analysis
20.
IUBMB Life ; 64(1): 81-6, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22131296

ABSTRACT

Testosterone (T) plays an important role in developing brain, dictating sex-specific behavior and physiology. 3α,5α-Reduced neurosteroids also regulate reproductive behavior. The key enzyme in the biosynthesis of these neurosteroids is 5α-reductase (5α-R), expressed as two isozymes, 5α-R1 and 5α-R2. In this study, T and sesame oil (vehicle) were administered during postnatal sexual differentiation of the central nervous system (CNS) and mRNA levels of 5α-R isozymes, were measured using quantitative RT-PCR in prefrontal cortex of male and female rats with different androgenic status at adulthood. Our results indicate that T concentrations during postnatal sexual differentiation of the rat CNS, among other sex-dependent factors, influence brain levels of 5α-R isozymes in adulthood and the pattern of their regulation by androgen hormones.


Subject(s)
3-Oxo-5-alpha-Steroid 4-Dehydrogenase/metabolism , Prefrontal Cortex/enzymology , Testosterone/physiology , 3-Oxo-5-alpha-Steroid 4-Dehydrogenase/genetics , Animals , Animals, Newborn , Female , Gene Expression , Isoenzymes/genetics , Isoenzymes/metabolism , Male , Prefrontal Cortex/drug effects , Prefrontal Cortex/growth & development , Prefrontal Cortex/metabolism , Rats , Rats, Wistar , Sex Characteristics , Testosterone/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...